• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,328.19 -516.33
( -0.66%)
Global Indices
Nasdaq
49,619.91 1.93
(0.00%)
Dow Jones
7,417.79 59.68
(0.81%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,228.01 -48.94
(-0.48%)
Forex
USD-INR
94.38 -0.30
(-0.31%)
EUR-INR
110.93 -0.26
(-0.23%)
GBP-INR
128.32 -0.39
(-0.30%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Zydus Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532321
INE010B01027
215.0764496
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ZYDUSLIFE
20.11
94475.31
EPS(TTM)
Face Value()
Div & Yield %
46.69
1
1.17
 

n2n technologies ltd
Infosys consolidated net profit rises 20.87% in the March 2026 quarter
Apr 24,2026
Net profit of Infosys rose 20.87% to Rs 8501.00 crore in the quarter ended March 2026 as against Rs 7033.00 crore during the previous quarter ended March 2025. Sales rose 13.38% to Rs 46402.00 crore in the quarter ended March 2026 as against Rs 40925.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 10.21% to Rs 29440.00 crore in the year ended March 2026 as against Rs 26713.00 crore during the previous year ended March 2025. Sales rose 9.61% to Rs 178650.00 crore in the year ended March 2026 as against Rs 162990.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales46402.0040925.00 13 178650.00162990.00 10
OPM %24.0724.13 -23.6724.07 -
PBDT12221.0010962.00 11 46186.0042420.00 9
PBT10797.009663.00 12 41284.0037608.00 10
NP8501.007033.00 21 29440.0026713.00 10